Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

Incidence of Postoperative Residual Neuromuscular Blockade in the Era of Sugammadex

This study is a prospective observational study. A total 52 patients will be included in this study. We will observe the incidence of postoperative residual neuromuscular blockade in patients receiving sugammadex.

Inclusion Criteria:

• Patients undergoing elective surgery under general anesthesia.
• American Society of Anesthesiologists grade 1, 2, or 3.
• Aged >18 years

Exclusion Criteria:

• Refusal to participate in the study
• Body Mass Index < 18.5 kg/m2 or > 35 kg/m2
• History of neuromuscular disease.
• History of allergy to neuromuscular blockade
• Scheduled to transfer to the intensive care unit